Drug Search Results
More Filters [+]

5-fluorouridine

Alternative Names: 5-fluorouridine
Latest Update: 2023-10-03
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: p53 Activator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: ECOG-ACRIN Cancer Research Group
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for 5-fluorouridine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Colorectal Cancer|Liver Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

The PUMP Trial

P3

Not yet recruiting

Liver Cancer|Colorectal Cancer

2029-06-30

Recent News Events